The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).
 
Nizar M. Tannir
Honoraria - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Mirati Therapeutics; Novartis
Travel, Accommodations, Expenses - Argos Therapeutics; Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
 
Thomas Powles
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
 
Bernard J. Escudier
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Travel, Accommodations, Expenses - Exelis
 
Viktor Grünwald
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; MOLOGEN; Novartis; Pfizer
Speakers' Bureau - Novartis
Research Funding - AVEO (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Pfizer
 
Cora N. Sternberg
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Sanofi
Research Funding - Exelixis (Inst)
 
Manuela Schmidinger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Novartis; Pfizer; Roche
Research Funding - Pfizer; Roche
 
Patrick Schoffski
Consulting or Advisory Role - 6th Element Capital (Inst); Adaptimmune (Inst); Amcure (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Epizyme (Inst); Genzyme (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); Medpace (Inst); Nektar (Inst); Novartis (Inst); Philogen (Inst); Pique (Inst); Plexxikon (Inst)
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); CoBioRes NV (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Plexxikon (Inst)
 
Cezary Szczylik
Employment - Astellas Pharma; Bayer; Pfizer
Honoraria - Astellas Pharma; Bayer; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Novartis; Pfizer
 
Katriina Johanna Peltola
Employment - Orion
Stock and Other Ownership Interests - Faron Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Orion; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Dmitry Nosov
Consulting or Advisory Role - Pfizer
 
Bohuslav Melichar
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche
 
Douglas O. Clary
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Patents, Royalties, Other Intellectual Property - Shared royalties from UCSF patent
 
Christian Scheffold
Employment - Exelis
Stock and Other Ownership Interests - Exelis
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy